Clinical Trial Update: A Study of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis [NA]

View source ↗

Summary

A completed clinical trial evaluated a probiotic food supplement containing Bifidobacterium infantis EVC001 in healthy breastfed infants at risk of developing a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Bifidobacterium infantis EVC001 (probiotic) (Bifidobacterium longum subsp. infantis)

Snippet

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) | Conditions: Healthy | NA | Status: COMPLETED